Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2008-04-30

Clinical Trial Update: Study to Explore the Effects of Two Hour Inhalation of Ultrafine Carbon Black Particles on Airway Inflammation in Asthmatics [NA]

View source ↗

Summary

The clinical trial explored whether two hours of inhaling ultrafine carbon black particles affected airway inflammation in individuals with asthma. The study st…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Fraunhofer-Institute of Toxicology and Experimental Medicine | Conditions: Asthma | NA | Status: COMPLETED